A double-blind, randomized, placebo-controlled trial of prostaglandin E 1 in liver transplantation
dc.contributor.author | Henley, Keith S. | en_US |
dc.contributor.author | Lucey, Michael R. | en_US |
dc.contributor.author | Normolle, Daniel P. | en_US |
dc.contributor.author | Merion, Robert M. | en_US |
dc.contributor.author | McLaren, Ian D. | en_US |
dc.contributor.author | Crider, Bruce A. | en_US |
dc.contributor.author | Mackie, Donald S. | en_US |
dc.contributor.author | Shieck, Victoria L. | en_US |
dc.contributor.author | Nostrant, Timothy T. | en_US |
dc.contributor.author | Brown, Kimberly A. | en_US |
dc.contributor.author | Campbell, Darrell A. | en_US |
dc.contributor.author | Ham, John M. | en_US |
dc.contributor.author | Appelman, Henry D. | en_US |
dc.contributor.author | Turcotte, Jeremiah G. | en_US |
dc.date.accessioned | 2006-04-28T16:56:46Z | |
dc.date.available | 2006-04-28T16:56:46Z | |
dc.date.issued | 1995-02 | en_US |
dc.identifier.citation | Henley, Keith S.; Lucey, Michael R.; Normolle, Daniel P.; Merion, Robert M.; McLaren, Ian D.; Crider, Bruce A.; Mackie, Donald S.; Shieck, Victoria L.; Nostrant, Timothy T.; Brown, Kimberly A.; Campbell, Darrell A.; Ham, John M.; Appelman, Henry D.; Turcotte, Jeremiah G. (1995)."A double-blind, randomized, placebo-controlled trial of prostaglandin E 1 in liver transplantation." Hepatology 21(2): 366-372. <http://hdl.handle.net/2027.42/38409> | en_US |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.issn | 1527-3350 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/38409 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7843707&dopt=citation | en_US |
dc.description.abstract | A double-blind placebo-controlled trial of intravenous prostaglandin PGE 1 (40 Μg/h) was conducted in adult orthotopic liver transplant recipients. Infusion was started intraoperatively and continued for up to 21 days. Patients were followed up for 180 days postoperatively. Among 172 patients eligible for treatment in the study, 160 could be evaluated (78 PGE 1 ; 82 placebo). Patient and graft survival were similar (PGE 1 : 16 deaths, 9 retransplantations [7 survivors]; controls: 15 deaths, 6 retransplantations [3 survivors]). In patients with surviving grafts, however, PGE 1 administration resulted in a 23% shorter mean duration of hospitalization following transplantation (PGE 1 : 24.4 days; controls: 31.8 days; P = .02) and 40% shorter length of time postoperatively in the intensive care unit (PGE 1 : 8.2 days; controls 13.7 days; P = .05). Reduced needs for renal support ( P = .03) or surgical intervention other than retransplantation ( P = .02) were also noted with PGE 1 use. Further, PGE 1 administration resulted in a trend toward improved survival rates in patients with mild renal impairment (preoperative serum creatinine 1.5 mg percent or greater; P = .08). Neither the incidence of acute cellular rejection nor of primary nonfunction was significantly different in the two groups. Phlebitis was the only complication that was more common during PGE 1 administration, (PGE 1 : 9; controls: 4). These results suggest that PGE 1 use in hepatic allograft recipients reduces morbidity and may result in sizable cost reductions. (H EPATOLOGY 1995;21:366–372.) | en_US |
dc.format.extent | 795084 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | W.B. Saunders | en_US |
dc.publisher | Wiley Periodiocals, Inc. | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Hepatology | en_US |
dc.title | A double-blind, randomized, placebo-controlled trial of prostaglandin E 1 in liver transplantation | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI ; Department of Internal Medicine, Division of Gastroenterology, 3912 Taubman Center, University of Michigan Medical Center, Ann Arbor, MI 48109–0362 | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Departments of Internal Medicine, Division of Gastroenterology, Anesthesiology, Surgery, and Pathology, the University of Michigan Medical School; and the School of Public Health, Division of Biostatistics, the University of Michigan, Ann Arbor, MI | en_US |
dc.identifier.pmid | 7843707 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/38409/1/1840210216_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/hep.1840210216 | en_US |
dc.identifier.source | Hepatology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.